Profund Advisors’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$275K	Buy	9,809 +1,595	+19%	+$52.3K	0.01%	804
2025 Q4	$307K	Sell	8,214 -2,589	-24%	-$85.1K	0.01%	852
2025 Q3	$298K	Buy	10,803 +520	+5%	+$17.9K	0.01%	738
2025 Q2	$325K	Sell	10,283 -356	-3%	-$11.5K	0.01%	646
2025 Q1	$353K	Sell	10,639 -440	-4%	-$15.8K	0.02%	597
2024 Q4	$381K	Buy	11,079 +4,651	+72%	+$160K	0.01%	654
2024 Q3	$257K	Sell	6,428 -1,129	-15%	-$39.7K	0.01%	895
2024 Q2	$228K	Buy	7,557 +758	+11%	+$22.8K	0.01%	909
2024 Q1	$228K	Sell	6,799 -4,718	-41%	-$151K	0.01%	1009
2023 Q4	$372K	Buy	11,517 +3,187	+38%	+$89K	0.02%	673
2023 Q3	$273K	Sell	8,330 -1,968	-19%	-$68.3K	0.02%	709
2023 Q2	$362K	Buy	10,298 +287	+3%	+$9.91K	0.02%	622
2023 Q1	$327K	Buy	10,011 +6,198	+163%	+$282K	0.02%	676
2022 Q4	$210K	Buy	+3,813	New	+$210K	0.01%	884